1. Home
  2. ZS vs KVUE Comparison

ZS vs KVUE Comparison

Compare ZS & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZS
  • KVUE
  • Stock Information
  • Founded
  • ZS 2007
  • KVUE 2022
  • Country
  • ZS United States
  • KVUE United States
  • Employees
  • ZS N/A
  • KVUE N/A
  • Industry
  • ZS EDP Services
  • KVUE Specialty Chemicals
  • Sector
  • ZS Technology
  • KVUE Consumer Discretionary
  • Exchange
  • ZS Nasdaq
  • KVUE Nasdaq
  • Market Cap
  • ZS 45.0B
  • KVUE 41.0B
  • IPO Year
  • ZS 2018
  • KVUE 2023
  • Fundamental
  • Price
  • ZS $272.52
  • KVUE $21.62
  • Analyst Decision
  • ZS Buy
  • KVUE Buy
  • Analyst Count
  • ZS 34
  • KVUE 12
  • Target Price
  • ZS $296.73
  • KVUE $24.38
  • AVG Volume (30 Days)
  • ZS 1.4M
  • KVUE 18.4M
  • Earning Date
  • ZS 09-02-2025
  • KVUE 08-07-2025
  • Dividend Yield
  • ZS N/A
  • KVUE 3.79%
  • EPS Growth
  • ZS N/A
  • KVUE 28.77
  • EPS
  • ZS N/A
  • KVUE 0.74
  • Revenue
  • ZS $2,546,757,000.00
  • KVUE $15,141,000,000.00
  • Revenue This Year
  • ZS $26.35
  • KVUE $2.34
  • Revenue Next Year
  • ZS $20.48
  • KVUE $3.56
  • P/E Ratio
  • ZS N/A
  • KVUE $29.20
  • Revenue Growth
  • ZS 25.46
  • KVUE N/A
  • 52 Week Low
  • ZS $153.45
  • KVUE $19.75
  • 52 Week High
  • ZS $318.46
  • KVUE $25.17
  • Technical
  • Relative Strength Index (RSI)
  • ZS 41.95
  • KVUE 50.06
  • Support Level
  • ZS $268.78
  • KVUE $21.35
  • Resistance Level
  • ZS $282.55
  • KVUE $21.85
  • Average True Range (ATR)
  • ZS 7.76
  • KVUE 0.53
  • MACD
  • ZS -0.08
  • KVUE 0.00
  • Stochastic Oscillator
  • ZS 26.34
  • KVUE 56.63

About ZS Zscaler Inc.

Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Share on Social Networks: